La Jolla Pharmaceutical's (LJPC) "Buy" Rating Reiterated at Cowen
's stock had its "buy" rating reiterated by analysts at Cowen in a report issued on Friday. They currently have a $55.00 target price on the biopharmaceutical company's stock.
from Biotech News
0 Comments